The Authors used flow cytometry to evaluate 62 patients who had undergone TURV for bladder tumour. The aim of the study was to investigate any relationship between an aneuploid polyclonal state and short-term local recurrence of the disease. Patients with recurrences after TURV had a high rate of aneuploidy. Despite the short follow up, these results show how important cytoflowmetry is in the clinico-therapeutic planning of bladder carcinoma.
KernW.H.: The grade and pathologic stage of bladder cancer. Cancer, 53: 1185–1189, 198.
2.
TortiF.M., LumB.L.: Superficial bladder cancer risk of recurrence and potential role for interferon therapy. Cancer, 59: 613–617, 1987.
3.
RoJ.Y., StaerkelG.A., AyalaA.G.: Cytologic and histologic features of superficial bladder cancer. Urologic Clinics of North America, 19: 435–440, 1992.
4.
BrendlerC.B.: Flow cytometry evaluation of urological malignancy. J. Urol., 139: 342–350, 1988.
5.
de VereWhite R.W., DeitchA.D.: The role of flow cytometry in urologic disease. Sem. Urol., 3: 132–141, 1985.
